Skip to main content
  • Letter to the Editor
  • Open access
  • Published:

Reduced T-cell densities in cranial nerves of patients who died with SARS-CoV-2 infection

SARS-CoV-2 patients show a highly variable disease course, ranging from asymptomatic infections to critical illness and death. Most of the fatalities occur in the older patient population and are linked to SARS-CoV-2-induced acute respiratory distress syndrome/diffuse alveolar damage (ARDS/DAD) of the lung, followed by multi-organ failure [20]. In addition to causing ARDS/DAD, SARS-CoV-2 infection may also affect the central and peripheral nervous system. Associations with Guillain-Barré syndrome (GBS), isolated cranial neuropathy, Miller Fisher syndrome and polyneuritis cranialis or chronic inflammatory demyelinating polyneuropathy (CIDP) have been described [3, 4, 6, 18]. Subclinical electrophysiological signs of trigeminal nerve involvement have been demonstrated recently in the majority of SARS-CoV-2 infected patients [2]. In line with clinical findings, in COVID-19 patients with isolated anosmia, the olfactory nerves displayed histological signs of inflammation and damage at autopsy [9] and also the olfactory bulb and tract showed axonal damage in some cases [7]. Although controversial, the olfactory route has been suggested as an entry point for SARS-CoV-2 to invade the CNS [8, 12]. In a subset of patients, viral protein was also detected within other cranial nerves (IX and X) [11]. Based on this, we hypothesized that the cranial nerves of patients who died with SARS-CoV-2 infection might show neuropathological signs of involvement.

We collected formalin-fixed olfactory tract and cranial nerves V, VII and X of 38 SARS-CoV-2-infected patients (24 male, 14 female; 63% male) and 52 control patients (37 male, 15 female; 71% male) at autopsy in the framework of the German COVID-19 autopsy registry [20]. The registry including the retrospective scientific work-up of autopsy-derived biomaterials was approved by the Ethics Committee, Medical Faculty, RWTH Aachen University (EK 092/20 & EK 460/20). There was no significant difference in gender distribution or mean age between the two groups: 66 ± 1.5 years for controls, 69 ± 1.8 years (SEM) in SARS-CoV-2 infected patients. 32 of the 38 SARS-CoV2-infected patients (86%) had contracted the wild-type virus before February 2021, when the alpha variant became predominant in Germany, two patients were infected during the beta wave (February-May/2021), two patients during the delta wave (June-December/2021) and two patients during the omicron wave (end of January and April 2022). At least 31 of the 38 SARS-CoV-2-infected patients (82%) had clinical and/or autoptic signs of ARDS/DAD and/or pneumonia. Clinical signs of cranial nerve involvement including loss of smell had not been reported for any of these patients. However, minor inflammation could remain clinically undetected, particularly since most critically ill COVID-19 patients undergo sedation during invasive ventilation where the clinical status of individual cranial nerves may remain undetected. We focused our analysis on the detection of inflammatory infiltrates as well as signs of neuropathy, this would include, but is not restricted to the detection of inflammatory neuropathies such as GBS [10]. Furthermore, it would allow us to detect peripheral nerve damage or neuroinflammation especially of the trigeminal nerve which has been found to be involved frequently based on electrophysiological data [2]. We performed immunhistochemistry for CD3-positive T-cells along with neurofilament immunohistochemistry and haematoxylin–eosin staining of FFPE tissue of the olfactory tract and cranial nerves V, VII and X (Fig. 1). The average density of CD3+ T-cells within the examined control cranial nerves V, VII and X was 35.7 ± 3.5 T-cells/mm2 endoneurial area. T-cell density was highest in the trigeminal nerve (V; 53.2 ± 6.7 (SEM)), followed by the facial (VII; 34.7 ± 5.2 (SEM)) and vagal nerves (X; 21.3 ± 3.0 (SEM)). The olfactory tract, considered to be part of the CNS, showed the lowest T-cell density (13.8 ± 1.8 cells/mm2) within the control group. The rather high counts in the trigeminal nerve are in line with the results of a non-quantitative study reporting a “surprisingly” high number of T-cells in the trigeminal nerve and ganglion [13] that might be attributable to persistent herpes simplex virus infection of the trigeminal ganglion [19]. The T-cell counts observed in cranial nerves were similar to those previously reported for sural nerve biopsies (43 ± 13 T-cells/mm2) from patients with non-inflammatory neuropathies [1]. Compared to controls, the SARS-CoV-2 patients showed significantly lower densities of CD3+ T-cells in cranial nerves V, VII and X and a trend to lower T-cell densities in the olfactory tract (olfactory tract: 9.6 ± 1.4, V: 34.1 ± 6.9, p = 0.018; VII: 16.9 ± 2.5, p = 0.0009; X: 13.5 ± 3.9, p = 0.0039). We found no correlation between T-cell densities and age and/or gender. Neurofilament immunohistochemistry showed no overt axonal loss. In all nerves with at least 20 T-cells/mm2, we also performed CD8-immunohistochemistry, which revealed a high correlation between CD3 and CD8 in both controls and SARS-CoV-2 infected patients. Luxol-fast blue-PAS staining and MBP immunohistochemistry revealed no overt demyelination in any of the nerves with increased T-cell densities. To our knowledge, this data provides the first quantitative analysis of T-cell densities in olfactory tract and cranial nerves V, VII, and X in autopsy tissues. Building on these normative values, we showed that inflammatory infiltration of cranial nerves is not a common finding in SARS-CoV-2 infected patients. Instead, patients dying with SARS-CoV-2 infection show reduced T-cell densities in cranial nerves.

Fig. 1
figure 1

CD3+ T-cells in olfactory tract and cranial nerves V, VII and X in postmortem controls and SARS-CoV-2-infected patients. a Conventional haematoxylin–eosin staining (HE) and immunohistochemistry for neurofilament protein, CD3 and CD8 in a cross section of a control trigeminal nerve. Scale bar = 100 µm. b Quantification of CD3+ T-cell density in olfactory tract, cranial nerve V, VII and X in controls (n = 52) and SARS-CoV-2 infected patients (n = 38). Mann–Whitney test was used due to unequal variances. c No correlation between age and mean CD3+ T-cell density in controls (n = 57) and SARS-CoV-2 infected patients (n = 38); values as mean of CD3+ T-cell density in nerves V, VII and X. d Correlation between CD8+ and CD3+ T-cell densities in those nerves V, VII and X with CD3+ T-cell densities of at least 20/mm2 in controls and SARS-CoV-2-infected patients

At present we cannot determine the exact pathomechanisms responsible for the reduced T-cell counts, possible explanations include (1) immunocompromised state of patients dying from COVID-19, (2) immunosuppression due to viral infection, intensive care or therapy-related effects and (3) redistribution of immune cells to other organs upon SARS-CoV-2-infection. Peripheral blood lymphocytopenia, especially T-lymphopenia, is seen in many patients with acute SARS-CoV-2 infection, correlates with severe clinical outcomes and is accompanied by the proliferation of the CD8+ T-cell pool, reviewed by [14]. Similarly, peripheral blood lymphopenia is seen in other viral infections [5, 15]. In contrast, lymphocytic infiltration of the lung and other organs has been reported in fatal COVID-19 [16, 17], raising the possibility of T-cell redistribution within the body.

Availability of data and materials

All numerical data generated or analyzed during this study are included in this published article. Additional information is available from the corresponding author on reasonable request.


  1. Cornblath DR, Griffin DE, Welch D, Griffin JW, McArthur JC (1990) Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J Neuroimmunol 26:113–118.

    Article  CAS  Google Scholar 

  2. Cosentino G, Maiorano E, Todisco M, Prunetti P, Antoniazzi E, Tammam G, Quartesan I, Lettieri S, De Icco R, Corsico AG et al (2022) Electrophysiological evidence of subclinical trigeminal dysfunction in patients with COVID-19 and smell impairment: a pilot study. Front Neurol 13:981888.

    Article  Google Scholar 

  3. Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P, Harpe J, Greer C, Mints G, Salama G et al (2020) COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 95:221–223.

    Article  CAS  Google Scholar 

  4. Finsterer J, Scorza FA, Scorza C, Fiorini A (2022) COVID-19 associated cranial nerve neuropathy: a systematic review. Bosn J Basic Med Sci 22:39–45.

    Article  CAS  Google Scholar 

  5. Fox A, Le NM, Horby P, van Doorn HR, Nguyen VT, Nguyen HH, Nguyen TC, Vu DP, Nguyen MH, Diep NT et al (2012) Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses. PLoS ONE 7:e31535.

    Article  CAS  Google Scholar 

  6. Gutierrez-Ortiz C, Mendez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Manas R, de Aragon-Gomez F, Benito-Leon J (2020) Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology 95:e601–e605.

    Article  CAS  Google Scholar 

  7. Ho CY, Salimian M, Hegert J, O’Brien J, Choi SG, Ames H, Morris M, Papadimitriou JC, Mininni J, Niehaus P et al (2022) Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19. JAMA Neurol 79:544–553.

    Article  Google Scholar 

  8. Jiao L, Yang Y, Yu W, Zhao Y, Long H, Gao J, Ding K, Ma C, Li J, Zhao S et al (2021) The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys. Signal Transduct Target Ther 6:169.

    Article  CAS  Google Scholar 

  9. Kirschenbaum D, Imbach LL, Ulrich S, Rushing EJ, Keller E, Reimann RR, Frauenknecht KBM, Lichtblau M, Witt M, Hummel T et al (2020) Inflammatory olfactory neuropathy in two patients with COVID-19. Lancet 396:166.

    Article  CAS  Google Scholar 

  10. Maier H, Schmidbauer M, Pfausler B, Schmutzhard E, Budka H (1997) Central nervous system pathology in patients with the Guillain-Barre syndrome. Brain 120(Pt 3):451–464.

    Article  Google Scholar 

  11. Matschke J, Lutgehetmann M, Hagel C, Sperhake JP, Schroder AS, Edler C, Mushumba H, Fitzek A, Allweiss L, Dandri M et al (2020) Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 19:919–929.

    Article  CAS  Google Scholar 

  12. Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, Laue M, Schneider J, Brunink S, Greuel S et al (2021) Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 24:168–175.

    Article  CAS  Google Scholar 

  13. Mezey E, Szalayova I, Hogden CT, Brady A, Dosa A, Sotonyi P, Palkovits M (2021) An immunohistochemical study of lymphatic elements in the human brain. Proc Natl Acad Sci USA.

    Article  Google Scholar 

  14. Moss P (2022) The T cell immune response against SARS-CoV-2. Nat Immunol 23:186–193.

    Article  CAS  Google Scholar 

  15. Russell CD, Unger SA, Walton M, Schwarze J (2017) The human immune response to respiratory syncytial virus infection. Clin Microbiol Rev 30:481–502.

    Article  CAS  Google Scholar 

  16. Schaller T, Hirschbuhl K, Burkhardt K, Braun G, Trepel M, Markl B, Claus R (2020) Postmortem examination of patients with COVID-19. JAMA 323:2518–2520.

    Article  CAS  Google Scholar 

  17. Song JW, Zhang C, Fan X, Meng FP, Xu Z, Xia P, Cao WJ, Yang T, Dai XP, Wang SY et al (2020) Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun 11:3410.

    Article  CAS  Google Scholar 

  18. Taga A, Lauria G (2022) COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era. J Peripher Nerv Syst 27:4–30.

    Article  CAS  Google Scholar 

  19. Theil D, Derfuss T, Paripovic I, Herberger S, Meinl E, Schueler O, Strupp M, Arbusow V, Brandt T (2003) Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 163:2179–2184.

    Article  CAS  Google Scholar 

  20. von Stillfried S, Bulow RD, Rohrig R, Boor P, German Registry of Covid-19 Autopsies DC (2022) First report from the German COVID-19 autopsy registry. Lancet Reg Health Eur 15:100330.

    Article  Google Scholar 

Download references


This work was supported by the German Registry of COVID-19 Autopsies (, funded by the Federal Ministry of Health (ZMVI1-2520COR201) and the Federal Ministry of Education and Research within the framework of the Network of University Medicine (NATON, No. 01KX2121). We thank Regina Nitsche, Janine Reinartz and David Haas for technical support.

Author information

Authors and Affiliations



JB and JW designed the study, interpreted the data and wrote and revised the manuscript. JB also collected the nerve tissues and analyzed the stainings. JF provided material and revised the manuscript. SvS and PB organized the German COVID-19 autopsy registry and revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Juliane Bremer or Joachim Weis.

Ethics declarations

Ethics approval and consent to participate

The German COVID-19 autopsy registry, including the retrospective scientific work-up of autopsy-derived biomaterials was approved by the Ethics Committee, Medical Faculty, RWTH Aachen University (EK 092/20 & EK 460/20).

Consent for publication

Not applicable.

Competing interests

The authors have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bremer, J., Friemann, J., von Stillfried, S. et al. Reduced T-cell densities in cranial nerves of patients who died with SARS-CoV-2 infection. acta neuropathol commun 11, 10 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: